Levosimendan in ECMO: A Paradigm Shift or an Adjunctive Option?
Levosimendan, a calcium-sensitizing inodilator, has emerged as a promising adjunctive therapy in patients undergoing veno-arterial extracorporeal membrane oxygenation (V-A ECMO). Its pharmacodynamic profile, combining positive inotropy with vasodilation and mitochondrial protective effects, offers a...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-12-01
|
| Serija: | Future Pharmacology |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2673-9879/5/4/70 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|